Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study.

Callum JL, Cohen R, Cressman AM, Strauss R, Armali C, Lin Y, Pendergrast J, Lieberman L, Scales DC, Skeate R, Ross H, Cserti-Gazdewich C.

Transfusion. 2018 Sep;58(9):2139-2148. doi: 10.1111/trf.14820.

PMID:
30204946
2.

Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use.

Lin Y, Cohen R, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J.

Vox Sang. 2018 May;113(4):386-392. doi: 10.1111/vox.12647. Epub 2018 Mar 8.

PMID:
29516511
3.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J.

Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5. No abstract available.

PMID:
29305554
4.

Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness.

Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J; From the QUEST-Quality in Utilization Education and Safety in Transfusion-Research Collaborative.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26933. Epub 2017 Dec 29.

PMID:
29286568
5.

Audit of appropriate use of platelet transfusions: validation of adjudication criteria.

Etchells M, Spradbrow J, Cohen R, Lin Y, Armali C, Lieberman L, Cserti-Gazdewich C, Pendergrast J, Callum J.

Vox Sang. 2018 Jan;113(1):40-50. doi: 10.1111/vox.12550. Epub 2017 Oct 19.

PMID:
29052231
6.

Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information.

Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P.

Vox Sang. 2017 Jul;112(5):e22-e47. doi: 10.1111/vox.12509. Epub 2017 May 19. No abstract available.

PMID:
28524359
7.

Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information: summary.

Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P.

Vox Sang. 2017 Jul;112(5):487-494. doi: 10.1111/vox.12496. Epub 2017 May 19. No abstract available.

PMID:
28524235
8.

Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.

Cohen R, Escorcia A, Tasmin F, Lima A, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C.

Transfusion. 2017 Jul;57(7):1674-1683. doi: 10.1111/trf.14099. Epub 2017 Mar 28.

PMID:
28369916
9.

Improving transfusion practice with guidelines and prospective auditing by medical laboratory technologists.

Lin Y, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Rammler W, Skinner I, Callum J.

Transfusion. 2016 Nov;56(11):2903-2905. doi: 10.1111/trf.13848. No abstract available.

PMID:
28211959
10.

The association of fever with transfusion-associated circulatory overload.

Parmar N, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C.

Vox Sang. 2017 Jan;112(1):70-78. doi: 10.1111/vox.12473. Epub 2016 Dec 21.

PMID:
28001310
11.

Platelet transfusion reactions do not occur more often in recipients transfused with apheresis versus buffy coat platelet concentrates.

Cserti-Gazdewich C, Escorcia A, Pendergrast J, Lieberman L, Skeate R, Lin Y, Callum J.

Transfusion. 2016 Dec;56(12):3144-3146. doi: 10.1111/trf.13884. No abstract available.

PMID:
27933620
12.

Optimal conditions for the performance of a monocyte monolayer assay.

Tong TN, Burke-Murphy E, Sakac D, Pendergrast J, Cserti-Gazdewich C, Laroche V, Branch DR.

Transfusion. 2016 Nov;56(11):2680-2690. doi: 10.1111/trf.13766. Epub 2016 Aug 21.

PMID:
27546234
13.

Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness.

Spradbrow J, Cohen R, Lin Y, Armali C, Collins A, Cserti-Gazdewich C, Lieberman L, Pavenski K, Pendergrast J, Webert K, Callum J.

Transfusion. 2016 Oct;56(10):2466-2476. doi: 10.1111/trf.13737. Epub 2016 Jul 27.

PMID:
27465485
14.

Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.

Seki JT, Sakurai N, Moldenhauer S, Dam J, Atenafu EG, Yip PM, Mazzulli T, Henderson T, Pendergrast J, Cserti C, Velazquez JP, Simpson R, Felluga G, Messner HA, Lipton JH.

Curr Oncol. 2015 Oct;22(5):e357-63. doi: 10.3747/co.22.2620.

15.

Introduction of a closed-system cell processor for red blood cell washing: postimplementation monitoring of safety and efficacy.

Acker JP, Hansen AL, Yi QL, Sondi N, Cserti-Gazdewich C, Pendergrast J, Hannach B.

Transfusion. 2016 Jan;56(1):49-57. doi: 10.1111/trf.13341. Epub 2015 Oct 7.

PMID:
26444143
16.

The role of inflammation in intravenous immune globulin-mediated hemolysis.

Pendergrast J, Willie-Ramharack K, Sampson L, Laroche V, Branch DR.

Transfusion. 2015 Jul;55 Suppl 2:S65-73. doi: 10.1111/trf.13097. Review.

PMID:
26174900
17.

Western immunoblotting as a new tool for investigating direct antiglobulin test-negative autoimmune hemolytic anemias.

Bloch EM, Sakac D, Branch HA, Cserti-Gazdewich C, Pendergrast J, Pavenski K, Branch DR.

Transfusion. 2015 Jun;55(6 Pt 2):1529-37. doi: 10.1111/trf.13082. Epub 2015 Mar 24.

PMID:
25808506
18.

Mixed fields on RhD typing as an indication of loss of heterozygosity on chromosome 1p in acute myeloid leukemia.

Chow S, Pendergrast J, Ochoa-Garay G, Gupta V, Munir ME, Craddock KJ, Wei C, Kamel-Reid S, Cserti-Gazdewich CM.

Leuk Lymphoma. 2015 Jul;56(7):2196-9. doi: 10.3109/10428194.2014.982641. Epub 2015 Jan 14. No abstract available.

PMID:
25495174
19.

Platelet dysfunction as measured by a point-of-care monitor is an independent predictor of high blood loss in cardiac surgery.

Orlov D, McCluskey SA, Selby R, Yip P, Pendergrast J, Karkouti K.

Anesth Analg. 2014 Feb;118(2):257-63. doi: 10.1213/ANE.0000000000000054.

PMID:
24445626
20.

The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure.

Alam A, Cserti-Gazdewich C, Pendergrast J.

Can J Anaesth. 2014 Mar;61(3):284-6. doi: 10.1007/s12630-013-0099-0. Epub 2014 Jan 9. No abstract available.

PMID:
24402838

Supplemental Content

Loading ...
Support Center